FELBAMATE

Generic: FELBAMATE

Novitium Pharma LLCManufacturer
ORALRoute
FELBAMATEActive Substance
2019-05-31Original Approval

FELBAMATE is FDA application ANDA211333, sponsored by NOVITIUM PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
SEIZURE
234 reports
2
DRUG INEFFECTIVE
188 reports
3
OFF LABEL USE
114 reports
4
SOMNOLENCE
85 reports
5
TOXICITY TO VARIOUS AGENTS
70 reports
6
CONDITION AGGRAVATED
64 reports
7
DRUG INTERACTION
59 reports
8
CONVULSION
53 reports
9
FATIGUE
47 reports
10
GENERALISED TONIC-CLONIC SEIZURE
47 reports